Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years by Seini Moimoi | Feb 25, 2021 | Portfolio News
Talaris Therapeutics Appoints Four Vice Presidents in Areas of Strategic Importance by Seini Moimoi | Feb 25, 2021 | Portfolio News
Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day by Seini Moimoi | Feb 24, 2021 | Portfolio News
Dascena Announces FDA Breakthrough Device Designation Granted to Machine Learning Diagnostic Method by Seini Moimoi | Feb 24, 2021 | Portfolio News
Rapid Micro Biosystems Hires Senior Vice President of Strategy by Seini Moimoi | Feb 23, 2021 | Portfolio News
